⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL7649281 | 0.97 | TYR (0.37) | — | |
| SCHEMBL2857692 | 0.77 | — | — | |
| SCHEMBL1740865 | 0.77 | — | — | |
| SCHEMBL13581429 | 0.73 | — | — | |
| SCHEMBL15945083 | 0.73 | — | — | |
| SCHEMBL12154900 | 0.67 | TYR (0.31) | — | |
| SCHEMBL13713778 | 0.67 | — | — | |
| SCHEMBL18364939 | 0.65 | TYR (0.30) | — | |
| SCHEMBL16186887 | 0.65 | TYR (0.30) | — | |
| SCHEMBL9999455 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240076443-A1 | LACTIDE COMPOSITIONS AND POLYLACTIDES MADE THEREFROM | NATUREWORKS LLC (US) | 2024-03-07 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| US-6117223-A | Hot melt inks containing polyketones | XEROX CORPORATION (US) | 2000-09-12 | — | — | US | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| US-5877210-A | CONTROLLING IMMUNE RESPONSE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-03-02 | — | — | US | claimed |
| US-5618982-A | SIMPLE INDUSTRIAL PROCESS OF CATALYZING IN PRESENCE OF METALLIC PHOSPHATES | RHONE-POULENC CHIMIE (FR) | 1997-04-08 | — | — | US | claimed |
| US-5583242-A | VANADYL COMPLEXES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-10 | — | — | US | claimed |
| US-5565491-A | FOR TREATMENT OF DISEASES MARKED BY MALIGNANT PROLIFERATION OF B CELLS, SUCH AS LEUKEMIA AND LYMPHOMAS; ANTICARCINOGENIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-10-15 | — | — | US | claimed |
| US-20250346715-A1 | PLANT AND EFFICIENT PROCESS FOR PRODUCING POLYLACTIC ACID | SULZER MANAGEMENT AG (CH) | 2025-11-13 | — | — | US | disclosed |
| US-20250289925-A1 | PLANT AND EFFICIENT PROCESS FOR PRODUCING POLYLACTIC ACID USING LACTIDE OBTAINED FROM POLYLACTIC ACID DEVOLATILIZATION | SULZER MANAGEMENT AG (CH) | 2025-09-18 | — | — | US | disclosed |
| CN-119487102-A | Apparatus and efficient method for producing polylactic acid using lactide obtained from devolatilization of polylactic acid | 苏尔寿管理有限公司 | 2025-02-18 | — | — | CN | disclosed |
| EP-4496828-A1 | A PLANT AND AN EFFICIENT PROCESS FOR PRODUCING POLYLACTIC ACID | Sulzer Management AG (CH) | 2025-01-29 | — | — | EP | disclosed |
| EP-4496827-A1 | A PLANT AND AN EFFICIENT PROCESS FOR PRODUCING POLYLACTIC ACID USING LACTIDE OBTAINED FROM POLYLACTIC ACID DEVOLATILIZATION | Sulzer Management AG (CH) | 2025-01-29 | — | — | EP | disclosed |
| US-20240076443-A1 | LACTIDE COMPOSITIONS AND POLYLACTIDES MADE THEREFROM | NATUREWORKS LLC (US) | 2024-03-07 | — | — | US | disclosed |
| US-5618982-A | SIMPLE INDUSTRIAL PROCESS OF CATALYZING IN PRESENCE OF METALLIC PHOSPHATES | RHONE-POULENC CHIMIE (FR) | 1997-04-08 | — | — | US | disclosed |
| US-5583242-A | VANADYL COMPLEXES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-10 | — | — | US | disclosed |
| US-5565491-A | FOR TREATMENT OF DISEASES MARKED BY MALIGNANT PROLIFERATION OF B CELLS, SUCH AS LEUKEMIA AND LYMPHOMAS; ANTICARCINOGENIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-10-15 | — | — | US | disclosed |
| EP-0735880-A1 | USE OF VANADIUM MOLYBDENUM OR TUNGSTEN COMPLEXES FOR CONTROLLING CELLULAR PROLIFERATION | Bristol-Myers Squibb Company (US) | 1996-10-09 | — | — | EP | disclosed |
| WO-1995020390-A1 | USE OF VANADIUM MOLYBDENUM OR TUNGSTEN COMPLEXES FOR CONTROLLING CELLULAR PROLIFERATION | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-08-03 | — | — | WO | disclosed |
| EP-0654460-A1 | Process for the C-alkylation of a ketonic compound | RHONE-POULENC CHIMIE (FR) | 1995-05-24 | — | — | EP | disclosed |